Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Skye Bioscience, Inc. (SKYE) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-26.57M |
|
-- |
|
-- |
|
$30.19M |
|
$-30.19M |
|
$3.64M |
|
$-26.56M |
|
$-27.92M |
|
$-26.57M |
|
$-26.57M |
|
$-26.57M |
|
$-27.93M |
|
$-30.19M |
|
$-29.30M |
|
36.49M |
|
36.49M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$70.83M |
|
$1.43M |
|
$1.94M |
|
$72.76M |
|
$4.34M |
|
-- |
|
$0.27M |
|
$4.61M |
|
$68.15M |
|
$68.15M |
|
$68.15M |
|
30.98M |
|
| Cash Flow Statement Financials | |
$-25.24M |
|
$-0.25M |
|
$83.56M |
|
$10.34M |
|
$68.42M |
|
$58.08M |
|
$8.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.32 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.98% |
|
-38.98% |
|
-36.51% |
|
-38.98% |
|
$2.20 |
|
$-0.70 |
|
$-0.69 |
|